How efficient is the Montelokast for Astma?

Montelokast is a drug that is classified as an antagonist of the leukotrien receptor, indicating that it inhibits the effect of leukotrieni, the compounds of the immune system involved in an inflammatory response. One of its effects in the respiratory system is to reduce bronchoconstriction or tightening the lung tissue, as well as inflammation of bronchial pipes. For this reason, asthma is launched as an asthma medicine. Different studies indicate contradictory expert opinions on the efficiency of Montelokast for Astma.

Since its effect takes some time for the body to affect, patients are administered by Montelokast for Astma in order to prevent attacks and chronic inflammation. However, it does not seem to be able to stop acute asthma attacks. Studies comparing the use of this medicine with placebo have found that the reactions to Montelokast are dependent on the dose. The doses of 2 milligrams (mg) provided chronic asthma relief that was better than placebo. Higher doses of 10 mgd 50 mg provided similar relief from chronic asthma symptomThe groups and groups of individuals using these doses have experienced more relief than 2 mg or placebo groups.

Another research has found that the greatest efficiency using metellukast for asthma is a combination of this drug with inhaled corticosteroids. Steroid drugs are useful in rapid suppression of the immune response and can be used for the relief of acute asthma attacks. Regular use of MONTELUKAST for asthma has allowed patients to reduce their corticosteroid doses and dose frequencies for these drugs. Asthma relief for individuals who have improved in this study have also improved in this study.

The

types of asthma differ and the use of montelucast for asthma with certain triggers can provide better relief than cases of this health with other causes. It seems that asthma caused by exercise is especially effective. Asthma -related cases seems to be aspiri -related, aspiri usenu nebo počáteční virové infekce jsou tímto lékem také zmírněny.

Zdá se, že nějaký výzkum týkající se Montelukastu zanechává otázky o jeho účinnosti. There are no studies that compare it with stimulating drugs such as theophyllin, which are also used to treat chronic asthma. Limited data suggest that this medicine can provide more effective treatment of asthma caused by effort than Salmeterol, but few other drug studies have been performed. Studies show that Montelokast provides greater relief from asthma symptoms than placebo, but does not necessarily apply that this drug is more effective than less expensive means already on the market.